https://assets.capyfin.com/instruments/678fdc13234e27009c5d5f22.png avatar
Clarivate
🇬🇧 NYSE:CLVT
•
Dec 31, 2024

Clarivate Q4 2024 Earnings Report

Clarivate reported a decline in revenue and net income for Q4 2024 while continuing strategic restructuring efforts.

Key Takeaways

Clarivate's Q4 2024 revenue decreased by 3.0% year-over-year to $663.0 million, mainly due to divestitures. The company posted a net loss of $191.8 million, a significant improvement from the previous year's loss. Adjusted EPS came in at $0.21, down from $0.23. The company repurchased $200 million in shares and prepaid $198 million of debt as part of its capital allocation strategy.

Total revenue decreased by 3.0% to $663.0 million due to divestitures.

Net loss improved significantly to $191.8 million from $843.9 million in Q4 2023.

Adjusted EPS decreased to $0.21 from $0.23 in the prior-year quarter.

Clarivate repurchased $200 million in shares and prepaid $198 million of debt.

Total Revenue
$663M
Previous year: $684M
-3.0%
EPS
$0.21
Previous year: $0.23
-8.7%
Adjusted EBITDA
$285M
Previous year: $298M
-4.3%
Subscription Revenue
$407M
Previous year: $411M
-0.9%
Re-occurring Revenue
$112M
Previous year: $119M
-6.0%
Cash and Equivalents
$295M
Previous year: $371M
-20.4%
Free Cash Flow
$59.1M
Previous year: $127M
-53.5%
Total Assets
$11.5B
Previous year: $12.7B
-9.6%

Clarivate Revenue

Clarivate EPS

Clarivate Revenue by Segment

Forward Guidance

Clarivate expects flat recurring organic revenue growth in 2025 and plans to discontinue low-margin transactional products.

Positive Outlook

  • Clarivate expects recurring organic revenue to remain stable in 2025.
  • Company will continue focusing on subscription-based revenue growth.
  • Cost structure will be aggressively managed to improve profitability.
  • Capital allocation strategy includes continued share repurchases.
  • Ongoing AI-powered product innovations expected to drive long-term growth.

Challenges Ahead

  • Total revenue is expected to decline due to divestitures.
  • Discontinuation of certain products may lead to short-term revenue losses.
  • Macroeconomic challenges may impact transactional revenue streams.
  • Lower IP patent renewal volumes continue to affect re-occurring revenue.
  • Debt repayment obligations may limit near-term flexibility.